Healthcare provider profile · identity verified

Stephen Raymond Predebon, MD

Family Practice · COLUMBIANA, OH · NPI 1437654050

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	331	83
Rosuvastatin Calcium	Rosuvastatin Calcium	322	82
Atorvastatin Calcium	Atorvastatin Calcium	307	90
Amlodipine Besylate	Amlodipine Besylate	271	80
Levothyroxine Sodium	Levothyroxine Sodium	256	58
Metformin Hcl	Metformin Hcl	190	45
Omeprazole	Omeprazole	176	50
Pantoprazole Sodium	Pantoprazole Sodium	174	49
Metoprolol Succinate	Metoprolol Succinate	161	49
Losartan Potassium	Losartan Potassium	154	43
Albuterol Sulfate Hfa	Albuterol Sulfate	137	41
Gabapentin	Gabapentin	135	28
Sertraline Hcl	Sertraline Hcl	130	35
Hydrochlorothiazide	Hydrochlorothiazide	119	28
Fluticasone Propionate	Fluticasone Propionate	108	48
Duloxetine Hcl	Duloxetine Hcl	97	20
Januvia	Sitagliptin Phosphate	87	16
Eliquis	Apixaban	81	20
Doxycycline Hyclate	Doxycycline Hyclate	79	76
Prednisone	Prednisone	79	72
Furosemide	Furosemide	78	25
Montelukast Sodium	Montelukast Sodium	75	16
Metoprolol Tartrate	Metoprolol Tartrate	74	23
Simvastatin	Simvastatin	73	21
Tamsulosin Hcl	Tamsulosin Hcl	71	25
Allopurinol	Allopurinol	68	22
Buspirone Hcl	Buspirone Hcl	57	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	55	16
Glipizide	Glipizide	52	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	15
Ropinirole Hcl	Ropinirole Hcl	50	suppressed
Jardiance	Empagliflozin	49	suppressed
Potassium Chloride	Potassium Chloride	49	16
Cephalexin	Cephalexin	48	45
Methylprednisolone	Methylprednisolone	48	47
Pravastatin Sodium	Pravastatin Sodium	47	14
Clopidogrel	Clopidogrel Bisulfate	46	suppressed
Synthroid	Levothyroxine Sodium	46	suppressed
Trazodone Hcl	Trazodone Hcl	46	14
Alprazolam	Alprazolam	43	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	suppressed
Famotidine	Famotidine	42	13
Metformin Hcl Er	Metformin Hcl	42	12
Pregabalin	Pregabalin	41	suppressed
Alendronate Sodium	Alendronate Sodium	39	12
Amoxicillin	Amoxicillin	35	33
Spironolactone	Spironolactone	35	suppressed
Ibuprofen	Ibuprofen	33	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	32	suppressed
Warfarin Sodium	Warfarin Sodium	31	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	30	23
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Nifedipine Er	Nifedipine	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Carvedilol	Carvedilol	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Azelastine Hcl	Azelastine Hcl	24	13
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Atenolol	Atenolol	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	17
Lovastatin	Lovastatin	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	18
Azithromycin	Azithromycin	18	18
Benazepril Hcl	Benazepril Hcl	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Methocarbamol	Methocarbamol	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Bumetanide	Bumetanide	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Cefdinir	Cefdinir	15	13
Insulin Lispro Kwikpen U-100	Insulin Lispro	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	15	suppressed
Tizanidine Hcl	Tizanidine Hcl	15	11
Fenofibrate	Fenofibrate	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Colchicine	Colchicine	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Solifenacin Succinate	Solifenacin Succinate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Baclofen	Baclofen	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Clonidine	Clonidine	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Verapamil Hcl	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error